ask="20.01"
ask_size="100"
average_daily_volume="404103"
bid="18.95"
bid_size="300"
book_value="8.16"
change="+0.27"
change_from_200_day_moving_average="-0.41"
change_from_50_day_moving_average="-0.83"
change_from_52_week_high="-5.36"
change_From_52_week_low="7.61"
change_in_percent="+1.43%"
close="19.21"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.14"
ebitda="-16.56M"
eps_estimate_current_year="-1.32"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.11"
ex_dividend_date="N/A"
float_shares="21949000"
high="19.54"
high_52_weeks="24.57"
last_trade_date="1/12/2017"
last_trade_price="19.21"
last_trade_size="14820"
last_trade_time="4:00pm"
low="18.73"
low_52_weeks="11.60"
market_capitalization="724.83M"
moving_average_200_day="19.62"
moving_average_50_day="20.04"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="34.67"
open="18.79"
pe_ratio="N/A"
peg_ratio="-0.74"
percent_change_from_200_day_moving_average="-2.07%"
percent_change_from_50_day_moving_average="-4.16%"
percent_change_from_52_week_high="-21.82%"
percent_change_from_52_week_low="+65.60%"
previous_close="18.94"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.32"
price_per_sales="5.64"
revenue="126.71M"
shares_outstanding="37732000"
short_ratio="13.96"
stock_exchange="NGM"
symbol="RTRX"
volume="534122"
weeks_range_52="11.60 - 24.57"
